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Abstract
When tissue engineering strategies rely on the combination of three-dimensional (3D) polymeric or
ceramic scaffolds with cells to culture implantable tissue constructs in vitro, it is desirable tomonitor
tissue growth and cell fate to be able tomore rationally predict the quality and success of the construct
upon implantation. Such a 3D construct is often referred to as a ‘black-box’ since the properties of the
scaffoldsmaterial limit the applicability ofmost imagingmodalities to assess important construct
parameters. These parameters include the number of cells, the amount and type of tissue formed and
the distribution of cells and tissue throughout the construct. Immunolabeling enables the spatial and
temporal identification ofmultiple tissue types within one scaffoldwithout the need to sacrifice the
construct. In this report, we concisely review the applicability of antibodies (Abs) and their
conjugation chemistries in tissue engineered constructs.With some preliminary experiments, we
show an efficient conjugation strategy to couple extracellularmatrix Abs tofluorophores. The
conjugated probes proved to be effective in determining the presence of collagen type I and type II on
electrospun and additivemanufactured 3D scaffolds seededwith adult human bonemarrowderived
mesenchymal stromal cells. The conjugation chemistry applied in our proof of concept study is
expected to be applicable in the coupling of any other fluorophore or particle to theAbs. This could
ultimately lead to a library of probes to permit high-contrast imaging by several imagingmodalities.
1. Introduction
Tissue engineering approaches for cartilage and bone
regeneration often involve the use of three-dimen-
sional (3D) synthetic polymeric or ceramic scaffolds
with a certain mechanical integrity to mimic the
natural native environment. Scaffolds can be
implanted directly into the defect site, in which they
are expected to attract cells and facilitate tissue
ingrowth. Another approach is based on in vitro
culture of scaffolds combined with autologous (stem)
cells to be able to control culture parameters and
therewith steer the cell fate and tissue growth into a
desired lineage. In both cases, our understanding of
the biological phenomena occurring within the pore
network of 3D scaffolds is often limited. Real time
monitoring of such phenomena offers a tool to also
advance the design of scaffolds which can better
control cell fate and tissue growth. In particular,
monitoring and being able to discriminate between
different types of collagen would be important to
further understand tissue morphogenesis in scaffolds.
Collagen is the most abundant protein in mammals,
representing about 30% of the total protein mass.
There are currently 28 different collagen types dis-
covered. Collagen type I is the most common and can
be found in several tissues, while collagen type II is
most found in articular cartilage [1]. However, current
imaging techniques are hindered by the scaffolds
limited transparency, scaffolds geometry and a lack of
available methods to non-invasively assess cells and
tissues functionality [2].
In the past few decades, the need for non-invasive
monitoring methods has been widely acknowledged.
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Several imaging methods have been opted to over-
come transparency issues, such as ultrasound, nuclear,
photoacoustic, x-ray and magnetic resonance (MR)
based imaging modalities [3]. X-ray and MR imaging
have shown to be promising tools in quantification of
mineralization in bone tissue engineering [4, 5]. How-
ever, to date none of these methods enables the detec-
tion of multiple early tissue lineage markers with a
single cell-resolution in 3D without the need to com-
bine several imagingmodalities.
The evolution of bio-conjugation chemistry has
significantly contributed to the development of novel
and successful methods to label multiple components
within a single construct for imaging purposes. Anti-
bodies (Abs) stand out as probes due to their specifi-
city, affinity and versatility to target tissue specific
components. Abs are proteins belonging to the immu-
noglobulin group and one of the most important
defense mechanisms in vertebrate animals. In
research, they are used as highly specific probes in
order to identify and locate intra- and extracellular
proteins, differentiate cell types and separate proteins
[6]. Immunoglobulins are made from two identical
heavy chain (H, 55–70 kDa, either κ or λ) and two
identical light chain (L, 24–25 kDa, either γ, ε, δ, α,
or μ) peptides joined by disulfide bonds (figure 1(A)).
The Fc portion of Abs is constant and specific to the
animal in which the antibody is generated while the
Fab portion is variable and binds to the epitope part of
the antigen. A single antigen has multiple epitopes
(figure 1(B)) to allow Abs to recognize it. Monoclonal
antibodies are homogeneous and bind to a single epi-
tope on the antigen (figure 1(C)), whereas polyclonal
antibodies are immunochemically dissimilar, having
affinities to various epitopes of the same antigen
(figure 1(D)). A possible application of Ab-based
extracellular matrix (ECM) detection in 3D tissue
engineered scaffolds is schematically presented in
figure 1(E). Initially, only cells are present in the
in vitro culture (upper figure). Over time, the cells will
start to secrete specific ECM components such as col-
lagen to which a targeted label will bind.With increas-
ing concentration of ECM components, the binding of
labeled Abs will also increase, resulting in a higher
overall brightness of the substrate upon optical
detection.
The direct conjugation of antibodies to detectable
labels or agents allows the combination of the label
properties with the high specificity and selectivity of
antibodies [7]. Three main label types can be dis-
tinguished: Ab [8–11] or enzymes [12, 13] based detec-
tion with fluorophores, or particulate based labeling
[6, 14]. Fluorescent immuno-labels enable the detec-
tion of specific components qualitatively and quanti-
tatively by detecting light emitted from a fluorophore
with a different wavelength than the light used to
excite the fluorophore [6]. Antibody conjugated parti-
cles were developed already decades ago for the immu-
nolabeling of specific ECM components in scanning
electron microscopy analysis, although the required
Figure 1.A schematic representation of an immunoglobulinG (IgG) antibody. IgG is a single proteinmade from four peptides joined
by disulfide bonds (A). There is a single constant region containing the Fc portion and species-specific antigens. The variable region
contains the Fab portion that binds the epitope portion of the antigen (B).Monoclonal antibodies react with a specific epitope of an
antigen (C)while polyclonal antibodies react with various epitopes (D). Fluorescent labeled Abs can enable the localization of specific
biological components within 3D tissue engineering constructs over time (E), from top to bottom increasing in culture time. Figures
are not to scale.
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sample processing made real-time monitoring impos-
sible [14]. To date, particle based labels comprise a
wide range of materials from heavy metals such as col-
loidal gold or small gold particles [14–16] to magnetic
beads [17–19], radioactive components [9, 20, 21] and
combinations of, for example, microbeads and cova-
lently bound or entrappedfluorescentmoieties [22].
The reactivity of an antibody is similar as for pro-
teins determined by its amino acid composition and
tertiary structure [23]. Understanding the functional
groups available on an antibody is vital for finding the
most appropriate conjugationmethod.Most Ab label-
ing strategies use one of the three types of available
reactive groups. These groups comprise primary
amines (–NH2), sulfhydryl groups (–SH) and carbohy-
drates (sugars) [24, 25]. Primary amines are the most
commonly used groups for conjugation, since they are
abundant, widely distributed and easily modified due
to their reactivity and location on the surface of the
antibody [26]. The N-hydroxysuccinimidyl ester
(NHS ester) reactive group is the most specific and
efficient reagent to target primary amines [26]. The
only drawback of this strategy is that it may cause a sig-
nificant decrease in the antigen-binding activity of the
antibody [27]. This is due to the presence of primary
amines in that site, which can also be modified. More-
over, lysines, on which primary amines can be found,
have a positive net charge while fluorophores have
negative net charge, which may alter antibody con-
formation and activity upon conjugation. This
decrease in activity is particularly noticeable when
working with monoclonal antibodies or when
attempting to achieve a higher degree of labeling
(DOL) [23]. The second possible target labeling Abs is
via sulfhydryls. Disulfide bonds are important in Ab
function as they contribute to covalently connect the
twoAb halves at the hinge region. Because disulfides in
the hinge region are the most susceptible to reduction,
a commonly utilized method to cleave these disulfides
bridges is by introducing papain [23]. Papain induced
cleavage splits the antibody into monovalent halves
without changing the antigen-binding site and ensures
consistent labeling at a defined location and degree.
The third useful target for labeling nanoparticles with
antibodies is carbohydrate moieties [23]. Labeling car-
bohydrates requires more steps than labeling amines
because carbohydrates must first be oxidized to obtain
reactive aldehydes. Recently, Shrestha et al performed
an extensive study on the application of the three pre-
viously mentioned conjugation methods to conjugate
a specific Ab to one type of fluorophore [23]. They
concluded that amine based conjugationwas by far the
best technique due to its simplicity, rapidity, ease of
operation, higher conjugate yield and lower costs. To
enable the direct coupling of a label to the Ab via
–NH2, –SH or –CHO groups to form a detectable Ab,
functionalization of the label and/or Ab is required.
Several well-known strategies to couple a label cova-
lently to the reactive groups of the Ab are via
maleimide activation, active ester formation and bio-
tin-avidin or biotin-streptavidin coupling [28, 29].
Furthermore, some non-covalently coupling methods
are developed via hydrophobic interactions, electro-
static association with the particles coating, ligand
coordination such as thiols and histidines and nickel
mediated assembly of histidine to carboxyl groups.
The aim of this study was to develop a protocol for
the conjugation of bone and cartilage specific Abs to be
able to monitor ECM formation in 3D tissue engi-
neered constructs. The probes have been developed
considering that they should provide enhanced con-
trast in imaging modalities such as MRI, micro-CT or
nuclear imaging for which transparency of the con-
struct does not form an issue. Therefore, the conjuga-
tion chemistry should be compatible with particles
that could be applied as contrast agents. Here, we
chose to optimize and test anti-collagen-I and anti-
collagen-II Abs conjugated with fluorescent probes as
a proof of concept.We have validated the binding spe-
cificity with collagen type-I and collagen type-II on
collagen type-I coated glass slides, native cartilage and
bone tissue sections and on 3D tissue engineered
constructs. We show that our conjugation protocol
provides a sufficient DOL retaining an adequate
antibody–antigen binding affinity to detect ECM
components.
2.Materials andmethods
2.1. Ab-dye conjugation procedure
Anti-collagen type-I (ab34710, Abcam®) and anti-
collagen type-II (ab34712, Abcam®) (both polyclonal,
produced in rabbit), the dyes ATTO 488 NHS-ester
(ATTO-TEC GmbH) and ATTO-594 NHS-ester
(ATTO-TEC GmbH) and Zeba™ Micro Spin Desalt-
ing Columns (40 K MWCO, 75 μl, Thermo Fisher
Scientific) were used. Prior to use, the buffer in the
columns was exchanged to phosphate buffered saline
(PBS) with 0.02M sodium azide according to manu-
factures instruction. Sodium azide was used as a
preservative to inhibit the growth of contaminants
such as bacteria or fungi in the antibody solutions.
Before the conjugation step, 10 μl of antibody solution
was passed through the column once in order to
exchange the antibody buffer solution to PBS solution.
The product was collected in an amber colored 1.5 ml
eppendorf tube. To adjust the pH to the optimal
conjugation value (pH= 8.3), sodium bicarbonate
(1M, pH= 8.3) was added to the antibody solution.
On the first use, the dye was dissolved to 2 mgml−1 in
anhydrous DMSO according tomanufactures instruc-
tion, aliquot and stored at −20 °C for further experi-
ments. In order to obtain the desired DOL between 2
and 3 labels per antibody (higher DOL results in non-
functional antibodies), approximately 0.1 μl of dye
solution were added to the antibody solution, mixed
and incubated for 1 h at RT with continuous shaking
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on an oscillating x–y plate. The conjugate solution was
then passed three times through new desalting
columns to remove any unconjugated dye. An ND100
spectrophotometer (Nanodrop Technologies, USA)
was utilized to analyze the obtained concentration and
ensure that the reaction occurred as expected. If
required, BSA was added to increase the solution
concentration above 1 mgml−1. The anti-collagen
type-I conjugated ATTO 488 dye will further be
referred to as ‘anti-col-I’. The anti-collagen type-II
conjugated ATTO 594 dye will further be referred to as
‘anti-col-II’. The conjugate solution was stored at
4 °C. As positive control to assess conjugates function-
ality, the same anti-collagen type-I or type-II antibody
and a secondary anti-rabbit antibody conjugated to an
Alexa-Fluor 488 fluorophore were used in several
experiments as a positive control and will be further
referred to as ‘control probe’.
2.2. Conjugate characterization
The efficiency of the procedure and DOL of the
antibody-dye conjugate were determined with a
ND1000 spectrophotometer (Nanodrop Technolo-
gies, USA). The following equation (equation (1)),
based on the Lambert–Beer law, was applied to
calculate theDOL:
* *
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e
e
e
= =
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prot prot
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where: A280 is the absorbance at 280 nm, Amax is the
absorbance at λmax, λmax is the wavelength where
the absorbance reaches its maximal value, CF is the
correction factor which depends on the dye’s spectral
properties, εprot is the molar extinction coefficient
(M−1 cm−1) of the pure protein at 280 nm and εmax is
themolar extinction coefficient (M−1 cm−1) of the dye
at its absorbance maximum. According to literature,
an ideal DOL sets between 2 and 8 depending on the
materials and methods utilized. Thus, we aimed at a
practical DOL of 4. SDS-PAGE was applied to get an
impression of the purity of the conjugate. The gel was
run at 70 V for stacking and then shifted to 30 mA
until separationwas completed.
2.3. Scaffold fabrication
Scaffolds were fabricated as described before, from
300PEOT55PBT45 (300/55/45) (PolyVation, The
Netherlands), a block copolymer composed of poly
(ethylene oxide terephthalate) (PEOT) and poly(buty-
lene terephthalate) (PBT) with a weight ratio of 55–45
for the two components, respectively, and a molecular
weight (MW) of the starting poly(ethylene glycol)
(PEG) segments of 300 Da used in the co-polymeriza-
tion process [30].
For electrospun (ES) scaffolds, a 28% (w/v) solu-
tion of 300/55/45 was prepared in a mixture of
chloroform
(CHCl3)-1,1,1,3,3,3-hexafluoro-2-propanol (HFIP)
with a volume ratio of 78:22. The solution was left stir-
ring at room temperature overnight. Subsequently,
the solution was loaded into a syringe and pumped at a
controlled flow rate using a syringe pump (KDS 100,
KD Scientific). PTFE tubing was used to connect the
syringe and a needle to which a high voltage was
applied (Gamma High Voltage Research Inc., FL,
USA). A stainless steel collector, covered by aluminum
foil, was used to collect the ES scaffold. A voltage of
12 kV was applied to a 1.2 mm needle, which was
placed at 25 cm from the collector. The flow rate was
set at 15 ml h−1, temperature to 25 °C, and humidity
to 30%. Upon reaching a sheet thickness of approxi-
mately 200 μm the electrospinning process was stop-
ped and disks with a diameter of 15 mmwere punched
out from the sheet.
Additive manufacturing by means of fused deposi-
tionmodeling with a bioscaffolder (SysENG, Germany)
was used to fabricate 3D plotted scaffolds, as described
before [31, 32]. The cylindrical shaped scaffolds had
diameter of 8mmaheight of 3 mm, afiber-to-fiber dis-
tance of 1000 μm, a fiber diameter of approximately
200 μm,and a layer thickness of 150 μm.
2.4. Cell culture
Bone marrow aspirates were obtained from donors after
written informed consent and human bone marrow
stromal cells (hMSCs) were isolated and proliferated as
previously described [33]. In short, 20 gauge needles were
used to re-suspend the aspirates, which were then plated
at a density of 5×105 cells cm−2. Cells were cultured in
hMSC proliferationmedium, for which the composition
is described in the supplementary data is available online
at stacks.iop.org/BMM/13/044102/mmedia, at 37 °C in
a humid atmosphere with 5%CO2. The culturemedium
was refreshed three times a week. After monolayer
expansion, cells were either cryopreserved or used for
further subculturing. Passage 3 hMSCs were detached
from the culture flasks by trypsinization upon reaching
70% confluence. Basic medium contained α-minimal
essentialmedium (LifeTechnologies), 10%heat-activated
fetal bovine serum (Cambrex), 0.2mM ascorbic acid
(Asap; Life Technologies), 2 mM L-glutamine (Life
Technologies), 100 unitsml–1 penicillin (Life Technolo-
gies), 10μgml−1 streptomycin (Life Technologies). Pro-
liferation medium consisted of basic medium
supplemented with 1 ngml−1 basic fibroblast growth
factor (Neuromics, Acris Antibodies, Germany). Osteo-
genic medium consisted of basic medium supplemented
with 10 nM dexamethasone. Chondrogenic medium
contains Dulbecco’s modified essential medium
(D-MEM) (LifeTechnologies)with0.2mMascorbic acid,
100 unitsml–1 penicillin (Life Technologies), 10μgml−1
streptomycin (Life Technologies), 50μgml−1 ITS-pre-
mix, 100μgml−1 sodium pyruvate, 10 ngml−1 TGF-β3
and 1μM dexamethasone. TGF-β3 and dexamethasone
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were freshly added every time that themediawas changed
during culture.
All scaffolds were sterilized by immersion in 70%
ethanol for at least 2 h, washed multiple times with
sterile PBS and subsequently placed into a non-treated
24 well plate (NUNC). The constructs were then incu-
bated at 37 °C in a humid atmosphere with 5% CO2
overnight in basic medium to pre-wet them. To pre-
vent the ES scaffold discs from floating, rubber
O-rings (Eriks BV, The Netherlands) were used to
hold the discs in place. After incubation, the medium
on the scaffold was aspirated, and 75 000 cells and
250 000 cells were seeded onto each ES scaffold and
plotted scaffolds, respectively. After 7 d of culture in
proliferation medium, the media was replaced with
chondrogenic and osteogenic medium to start differ-
entiation and cultured for additional 14 d.
2.5. Immunostaining
Glass slides with a diameter of 18 mm were immersed
in 10% acetic acid in ethanol for 30 min, followed by
100% ethanol rinses and dried in the oven at 50 °C.
Collagen type I from rat tail (BDBiosciences, TwoOak
Park. Bedford, USA)was diluted from a stock concen-
tration of 11.59 to 2 mgml−1 in a 0.02M acetic acid
solution. Glass slides were placed in a non-treated 12
well plate (NUNC) and 250 μl of collagen solution was
added. After 1 h incubation at 37 °C, glass slides were
washed three times with PBS to remove any remaining
acetic acid. Prior to Ab incubation, slides were blocked
with a buffer (0.1% Triton X-100, 1% BSA in PBS).
Afterwards, they were incubatedwith the fluorescently
conjugated primary Abs, at 4 °C, overnight. After
incubation, slides were washed three times with PBST
(0.1% Tween-20 in PBS) for 5 min each. The presence
of collagen coatingwas further confirmed by picosirius
red staining (supplementary figure 1(C)).
A 6 weeks old post-mortem rat was kindly pro-
vided by the department of Biomedical Signals and
Systems (BSS, MIRA institute, University of Twente).
Animal use was regulated by national laws on animal
experiments after approval from a local ethical com-
mittee. The tail and bone of the rat was isolated and
immersed in 12.5% EDTA, pH=8, for 5 weeks to
decalcify the tissues. EDTA was changed three times a
week. A series of increasing ethanol concentrations
(60%, 70%, 80%, 90%, 96%, 100%×2), 2 d per con-
centration, was used to dehydrate the tissue. Subse-
quently, the tissue was immersed in butanol overnight
and in eosin for 1 h to stain them with a pink color to
be able to localize the sample after embedding. Speci-
mens were embedded in paraffin for 5 d in a holder at
60 °C. Paraffin was changed after 2 d to remove any
traces of butanol. The sections were cut at room temp-
erature with 5 μm intervals. Prior to Ab incubation,
specimens were blocked with a buffer (0.1% Triton
X-100, 1% BSA in PBS). Incubation was performed
with the fluorescently conjugated primary Abs, at
4 °C, overnight. After incubation, specimens were
washed three times with PBST for 5 min each. After-
wards, specimens were incubated in a solution of 0.1%
Sudan Black B in 70% Ethanol for 20 min to mask
bone autofluorescence and washed three times with
PBS for 5 min each.
After 14 d of culture in differentiation media, the
cultured samples were washed once with PBS, fixed
with paraformaldehyde (4% in PBS) for 15 min and
stored in PBS at 4 °C. Prior to Ab incubation, con-
structs were blockedwith a buffer (0.1%TritonX-100,
1% BSA in PBS). Samples were incubated with both
anti-col-I and anti-col-II Abs, at 4 °C overnight. Con-
trol samples were incubated with primary Abs
(ab34710 and ab34712, Abcam®), at room temper-
ature, for 1 h. Then, constructs were washed once with
PBS and incubated with the corresponding secondary
antibody (anti-rabbit antibody conjugated to an
Alexa-Fluor 488 fluorophore) overnight, at 4 °C. After
incubation, constructs were washed three times with
PBST (0.1% Tween-20 in PBS) for 5 min each. After-
wards, samples were incubated in a solution of 0.1%
Sudan Black B in 70% Ethanol for 20 min to remove
polymer autofluorescence and then washed three
times with PBS for 5 min each. Cell nuclei labeling was
performed with 4′,6′Diamidin-2′-phenylindoldihy-
drochlorid (DAPI, 100 ng ml−1 in PBS, Sigma) and
actin filaments were stained with Phalloidin to visua-
lize the cytoskeleton. Samples were imaged using a
Nikon A1 confocal microscope (Nikon Instruments
Inc.).
3. Results and discussion
3.1. Ab and dye concentration by
spectrophotometry
To quantify the DOL after conjugation of the
fluorescent probe to the Ab, the absorbance spectrum
was analyzed with a ND1000 spectrophotometer
Figure 2. SDS pagewas run for anti-col-I and anti-col-II
conjugates. The ladders were placed in thefirst (1), third (3)
andfifth (5) lane and theirfluorescent bands are displayed in
green. Anti-col-II was located on the second column (2) and
is displayed in red. Anti-col-I was located in the fourth
column and is displayed in blue.
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(Nanodrop Technologies, USA). The CFs for ATTO
488 and for ATTO 594 were provided by the supplier
and found to be 0.1 and 0.51, respectively. The εmax
for ATTO 488 and for ATTO 594 were also provided
by the supplier and were 90 000 and
120 000 M−1 cm−1, respectively. The molar extinc-
tion coefficient for the AB (IgG) was set at
210 000 M−1 cm−1. The path length in all measure-
ments was set at 1 cm. For the anti-col-I the A280 was
found to be 0.877, while Amax was found to be 1.953
at approximately 500 nm.With these values the DOL
was determined according to equation (1) and found
to be around 6. For, anti-col-II conjugated to ATTO
594 the A280 was found to be 2.115, while Amax was
found to be 0.435 at approximately 500 nm. With
these values the DOL was determined according to
equation (1) and found to be around 4. Both values
are well under the optimal range for DOL which sets
between 2 and 8. An excessively high DOL may
denature the antibodies or reduce its antigen-binding
activity, decreasing its functionality. A low DOL will
result in a low signal. Further analysis of the probe
functionality will be accessed in the following section.
SDS-PAGE was performed before adding BSA to
the conjugate solution to get insight in the purity of the
probes solution (figure 2). In both antibody con-
jugated dyes, a strong fluorescent band was observed
in the top of the gel, where higherMWmolecules were
retained. Two other bands were observed at lower
MW. However, these bands seemed significantly
weaker compared to the ones in the top layer of the gel.
The probe solution was therefore considered suffi-
ciently purified with just low amounts of unconju-
gated label andAbs.
3.2. Cell culture
The ultimate goal of the probe developed here was to
be applied on culture systems to monitor and char-
acterize tissue formation in 3D scaffolds in vitro.
Firstly, the antigen affinity of the anti-col-I was
assessed on a pure collagen type-I coating (Rat) and
compared to the affinity of the commercially available
control probe (supplementary figure 1). It was
observed that both probes showed high binding
affinity with the collagen coating whereas no label was
detected on the surface of the glass slide. This was done
to ensure that the functionality of both conjugated
probes was preserved. The different net charges of the
fluorophore (−1) and the amine groups (+1) and the
possibility of fluorophore conjugation to the Ab
antigen-site could have reduced its final functionality,
even though the DOL was well between optimal
values. Anti-col-I and anti-col-II were further tested
on a histological section of demineralized rat tail and
bone tissue to get insights in non-specific binding
(figure 3), further confirming the successful synthesis
of the molecular probes. All structures were blocked
with a BSA based blocking buffer to prevent non-
specific binding and secondary Abs were applied to
probe successful blockage (supplementary figure 3).
Moreover, both control probes and anti-col-I and
anti-col-II showed similar detection sites (supplemen-
taryfigure 3).
The two probes were, then, applied on hMSCs cul-
tured for 14 d in osteogenic or chondrogenic medium
on ES and 3D plotted scaffolds (figure 4). ES scaffolds
showed randomly oriented fibers with a non-uniformly
distributed average diameter of 3.06±1.95 μm, with a
minimum diameter of approximately 1 μm and max-
imum fiber diameter of 8 μm. Conversely, 3D plotted
Figure 3. Fluorescentmicroscopy images of (A) tail and (B) bone sections, stained by anti-col-I (green) and anti-col-II (red). Scale bar:
512 μm.
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scaffolds showed well oriented fibers with an average
fiber diameter of 214.5±27.1 μm and a fiber spacing
of 498.4±46 μm.
Results showed that collagen type I was abun-
dantly produced by hMSCs in both scaffold types and
in both media. Collagen type II was hardly expressed
in osteogenic medium and minimally produced in
chondrogenic medium in both scaffold types, thus
suggesting better differentiation in osteogenic condi-
tions than in chondrogenic conditions. In our pre-
vious studies, we have also found similar results at a
genetic level, where it was clear that hMSCs on PEOT/
PBT scaffolds showed upregulated early markers for
both osteogenesis and chondrogenesis, accompanied
Figure 4. Fluorescentmicroscopy images of hMSCs cultured in (A)–(F) electrospun and (GL) 3Dplotted scaffolds in chondrogenic
(A)–(C), (G)–(I) and osteogenic (D)–(F), (J)–(L)media, showing collagen type I and collagen type II staining. In all four conditions (A),
(D), (G) and (J) collagen type I (green) is foundwith similar signal intensities as the actin counterstain (red), whereas collagen type II
was hardly detected compared to actin (B), (E), (H), (K). (C), (F), (I), (L)When staining collagen type I (green) and collagen type II
i(purple) it can clearly be observed that collagen type I ismore abundant for all conditions. The scale bars represent (A)–(F) 1 mmand
(G)–(L) 500 μm.
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by higher expression of alkaline phosphatase activity
and glycosaminoglycans, respectively [30].
The anti-co-II probe was also tested against a con-
trol probe in osteogenic conditions on 3D plotted scaf-
folds (supplementary figure 2). The circular pattern
formed by the seeded hMSCs has shown to be typical
for tissue formation in this type of scaffolds, where
cells initially attach on the struts of the scaffolds and
over time close the pore. This pattern of tissue growth
is one of the processes that can be considered impor-
tant to assess during culture to monitor the type and
morphology of the ECM that was produced. Collagen
type-I was found both with anti-col-I and with the
control probe. In both samples, the collagen type-I
showed to be distributed over the areas where cells
were located as well. Therefore, the newly developed
probes of this study can be considered successfully
applied. The high DOL obtained in this study could
have interfered with the binding affinity of the Ab to
the antigen, which could explain the lower brightness
of the anti-col-I compared to the control probe. The
stability of the label was not expected to result in this
lower brightness, since theATTO-dyes applied in anti-
col-I and anti-col-II are generally more stable than the
fluorophore coupled the control probe. Yet, there are
some other advantages for the conjugated antibodies.
They do not require a secondary incubation with a sec-
ondary antibody labeled antibodies, which reduces the
amount of protocol steps and unspecific secondary
antibody binding. These conjugated-antibodies allow
the use of two or more antibodies raised in the same
animal, e.g. useful in this study due to the limited
availability of collagen II antibodies. Finally, they allow
the conjugation of any fluorophore or nanoparticle
with a NHS-ester, especially important in cases in
which they are not commercial available and readily
conjugated for secondary incubation.
In theory, the conjugation chemistry applied on
this Ab allows for the coupling to any other kind of
labeling particle, thus being applicable also to the near
infrared spectrum. Applying other imaging modalities
would permit imaging of collagens at greater depths
without the need to stain the cells. By coupling col-
lagen type detection to a responsive scaffold material,
for example a sort of actuating system to locally
administer certain stimuli, more insight in collagen
production and collagen orientation could be realized.
4. Conclusion
The main objective of this study was the optimization
and validation of a method that could be used to
functionalize particles and fluorophores to be applied
in several imagingmodalities. Basedona concise review
on Abs and available conjugation strategies, the most
promising method for application in 3D tissue
engineered scaffolds was chosen and optimized. Both
anti-collagen type-I and anti-collagen type-II Abs
were successfully conjugated to their respective dyes.
The anti-col-I probe showed a similar selectivity to a
control probe targeting collagen type-I in all tests
performed, whereas anti-col-II revealed no matura-
tion of chondrogenic differentiation of hMSCs in
both ES and 3D plotted scaffolds. Yet, from the
successful collagen type-I and type II detection, we
conclude that the conjugation via amines offers an
easy and feasible chemistry to obtain specific anti-
collagen-I and -II Abs coupled to several types of
fluorophores and particles.
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